D

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Director Clinical Scientist

Clinical Research OperationsPosted on Nov 10
Full-timeWaltham, MA, USA$222k - $258k

About the Job

Requirements

  • An advanced degree in life sciences, healthcare, pharmacy, medicine, nursing, or a clinically relevant discipline is required.
  • At least 8 years of relevant experience in clinical development, clinical science, clinical research, or related roles in the pharmaceutical or biotechnology industry is required.
  • Experience supporting or leading interventional clinical trials across multiple development phases is required.
  • Experience supporting global, late-stage clinical trials and submissions is required.
  • Demonstrated understanding of clinical development strategy, study design, protocol development, regulatory documentation, data review, clinical trial execution, and study reporting is required.
  • Strong knowledge and experience with Good Clinical Practice, International Council for Harmonisation guidelines, the U.S. Food and Drug Administration, the European Medicines Agency, and other applicable global clinical-trial regulatory requirements is required.
  • Experience developing or contributing to clinical and regulatory documents, including protocols, protocol amendments, informed consent forms, investigator brochures, clinical study reports, briefing documents, regulatory responses, abstracts, posters, and manuscripts is required.
  • Ability to interpret clinical, safety, biomarker, pharmacodynamic, efficacy, and endpoint data and translate findings into clear insights, recommendations, and communications is required.
  • Experience with clinical data review tools and systems, including electronic data capture systems, data listings, patient profiles, dashboards, Excel, and PowerPoint, is required.
  • Ability to lead complex clinical science workstreams, manage competing priorities, identify risks, resolve issues, and drive deliverables in a fast-paced, matrixed biotechnology environment is required.
  • Ability to collaborate cross-functionally and influence alignment across Clinical Development, Clinical Operations, Biostatistics, Data Management, Pharmacovigilance, Regulatory Affairs, Translational Medicine, Medical Affairs, external vendors, and study sites is required.
  • Strong written, verbal, and presentation skills to communicate complex scientific and clinical information clearly to internal and external audiences are required.
  • Strong scientific judgment, critical thinking, attention to detail, and problem-solving skills are required.
  • Ability to operate independently with sound judgment, accountability, urgency, and flexibility in a growing clinical-stage biotechnology company is required.
  • Ability to travel domestically and internationally for trial site visits, investigator meetings, advisory boards, scientific congresses, and internal meetings, approximately 20%, is required.

Responsibilities

  • Serve as clinical science lead or key clinical science contributor for assigned studies, partnering with the study medical director on study strategy, design, execution, data interpretation, and reporting.
  • Provide scientific input on study design, patient population, eligibility criteria, endpoints, biomarkers, assessments, visit schedules, and data collection strategies to ensure scientific soundness, operational feasibility, and alignment with program objectives.
  • Interpret emerging clinical data and translate findings into recommendations for study conduct, clinical development strategy, internal governance discussions, regulatory interactions, and external scientific communications.
  • Maintain current knowledge of rare disease, neuromuscular disease, genetic medicine, oligonucleotide therapeutics, clinical trial innovation, regulatory expectations, competitive developments, and relevant scientific literature.
  • Partner with Clinical Operations, Biostatistics, Data Management, Pharmacovigilance, Regulatory Affairs, Translational Medicine, Medical Affairs, Quality, contract research organizations, vendors, and other stakeholders to support high-quality study execution.
  • Monitor study progress, identify scientific, clinical, operational, or data-related risks, and work with cross-functional teams on practical mitigation strategies supporting quality, timelines, and patient safety.
  • Collaborate with Clinical Operations on oversight of study milestones and overall study metrics.
  • Represent Clinical Development on cross-functional study teams, workstreams, and governance discussions, providing scientific input and influencing alignment without direct authority.
  • Collaborate with investigators, key opinion leaders, external experts, contract research organizations, and vendors to support scientific exchange, study execution, issue resolution, and alignment with clinical development objectives.
  • Support the Study Medical Monitor in overseeing the contract research organization Medical Monitoring team, including reviewing meeting minutes and materials and supporting medical monitoring deliverables.
  • Support ongoing patient-level and aggregate clinical data review, including safety, efficacy, biomarker, pharmacodynamic, endpoint, and protocol-compliance data, to identify trends, insights, risks, protocol deviations, safety trends, patient profiles, and other potential issues.
  • Partner with Pharmacovigilance and Clinical Development colleagues on safety surveillance, signal evaluation, benefit-risk assessment, safety narratives, and timely escalation of clinically meaningful findings.
  • Lead or contribute to developing clinical study concepts, protocol synopses, protocols, protocol amendments, informed consent forms, investigator brochures, clinical study reports, briefing documents, regulatory responses, and other key clinical and regulatory deliverables.
  • Contribute to regulatory submissions and interactions by preparing, reviewing, and interpreting clinical content for Investigational New Drug applications, Clinical Trial Applications, briefing books, annual reports, Development Safety Update Reports, submission dossiers, and responses to regulatory questions.
  • Support investigator meetings, site engagement, advisory boards, data monitoring committee materials, steering committee materials, and other internal or external scientific forums as needed.
  • Contribute to internal and external presentations, abstracts, posters, manuscripts, publications, and other scientific communications that summarize clinical data clearly and accurately.
  • Mentor, coach, or guide clinical scientists, study team members, or cross-functional colleagues as appropriate, strengthening clinical science capabilities and execution quality.
  • Model the company's core values and demonstrate accountability, collaboration, urgency, integrity, scientific excellence, and commitment to patients in internal and external interactions.

Desired Qualifications

  • Experience in rare disease, neuromuscular disease, genetic medicines, oligonucleotide therapeutics, or other complex therapeutic areas is strongly preferred.
  • A PhD, Doctor of Pharmacy, Doctor of Medicine, or equivalent advanced degree is preferred.
  • Experience working with contract research organizations, investigators, study sites, key opinion leaders, advisory boards, or external experts is preferred.

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs